Logo image of MRTN

MARTEN TRANSPORT LTD (MRTN) Stock Fundamental Analysis

USA - NASDAQ:MRTN - US5730751089 - Common Stock

10.48 USD
-0.31 (-2.87%)
Last: 10/10/2025, 8:45:13 PM
10.48 USD
0 (0%)
After Hours: 10/10/2025, 8:45:13 PM
Fundamental Rating

4

MRTN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Ground Transportation industry. While MRTN has a great health rating, its profitability is only average at the moment. MRTN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MRTN was profitable.
MRTN had a positive operating cash flow in the past year.
In the past 5 years MRTN has always been profitable.
In the past 5 years MRTN always reported a positive cash flow from operatings.
MRTN Yearly Net Income VS EBIT VS OCF VS FCFMRTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

With a Return On Assets value of 2.11%, MRTN perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
MRTN has a Return On Equity (2.71%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 1.57%, MRTN perfoms like the industry average, outperforming 45.24% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MRTN is in line with the industry average of 7.77%.
The last Return On Invested Capital (1.57%) for MRTN is well below the 3 year average (6.79%), which needs to be investigated, but indicates that MRTN had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.11%
ROE 2.71%
ROIC 1.57%
ROA(3y)7.11%
ROA(5y)7.9%
ROE(3y)9.49%
ROE(5y)10.56%
ROIC(3y)6.79%
ROIC(5y)7.57%
MRTN Yearly ROA, ROE, ROICMRTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 2.27%, MRTN perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
MRTN's Profit Margin has declined in the last couple of years.
The Operating Margin of MRTN (2.01%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of MRTN has declined.
MRTN's Gross Margin of 32.33% is in line compared to the rest of the industry. MRTN outperforms 40.48% of its industry peers.
In the last couple of years the Gross Margin of MRTN has declined.
Industry RankSector Rank
OM 2.01%
PM (TTM) 2.27%
GM 32.33%
OM growth 3Y-33.12%
OM growth 5Y-18.27%
PM growth 3Y-31.71%
PM growth 5Y-17.35%
GM growth 3Y-2.3%
GM growth 5Y-1.52%
MRTN Yearly Profit, Operating, Gross MarginsMRTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MRTN is destroying value.
The number of shares outstanding for MRTN remains at a similar level compared to 1 year ago.
MRTN has less shares outstanding than it did 5 years ago.
There is no outstanding debt for MRTN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MRTN Yearly Shares OutstandingMRTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MRTN Yearly Total Debt VS Total AssetsMRTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 4.43 indicates that MRTN is not in any danger for bankruptcy at the moment.
The Altman-Z score of MRTN (4.43) is better than 83.33% of its industry peers.
MRTN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.43
ROIC/WACC0.17
WACC9.15%
MRTN Yearly LT Debt VS Equity VS FCFMRTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MRTN has a Current Ratio of 1.34. This is a normal value and indicates that MRTN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MRTN (1.34) is better than 64.29% of its industry peers.
A Quick Ratio of 1.34 indicates that MRTN should not have too much problems paying its short term obligations.
The Quick ratio of MRTN (1.34) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
MRTN Yearly Current Assets VS Current LiabilitesMRTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2

3. Growth

3.1 Past

The earnings per share for MRTN have decreased strongly by -51.85% in the last year.
MRTN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.56% yearly.
The Revenue for MRTN has decreased by -11.76% in the past year. This is quite bad
Measured over the past years, MRTN shows a small growth in Revenue. The Revenue has been growing by 2.71% on average per year.
EPS 1Y (TTM)-51.85%
EPS 3Y-31.11%
EPS 5Y-14.56%
EPS Q2Q%-10%
Revenue 1Y (TTM)-11.76%
Revenue growth 3Y-0.34%
Revenue growth 5Y2.71%
Sales Q2Q%-6.63%

3.2 Future

Based on estimates for the next years, MRTN will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.19% on average per year.
The Revenue is expected to decrease by -0.78% on average over the next years.
EPS Next Y-10%
EPS Next 2Y16.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.76%
Revenue Next 2Y-0.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MRTN Yearly Revenue VS EstimatesMRTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MRTN Yearly EPS VS EstimatesMRTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 40.31 indicates a quite expensive valuation of MRTN.
MRTN's Price/Earnings ratio is in line with the industry average.
MRTN's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.02.
The Price/Forward Earnings ratio is 22.83, which indicates a rather expensive current valuation of MRTN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MRTN is on the same level as its industry peers.
MRTN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 40.31
Fwd PE 22.83
MRTN Price Earnings VS Forward Price EarningsMRTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MRTN is valued cheaply inside the industry as 88.10% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.27
MRTN Per share dataMRTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

MRTN's earnings are expected to grow with 16.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.19%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.27%, MRTN has a reasonable but not impressive dividend return.
The stock price of MRTN dropped by -23.50% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
MRTN's Dividend Yield is rather good when compared to the industry average which is at 1.66. MRTN pays more dividend than 92.86% of the companies in the same industry.
MRTN's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.27%

5.2 History

The dividend of MRTN decreases each year by -14.12%.
MRTN has been paying a dividend for at least 10 years, so it has a reliable track record.
MRTN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-14.12%
Div Incr Years0
Div Non Decr Years2
MRTN Yearly Dividends per shareMRTN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

MRTN pays out 93.53% of its income as dividend. This is not a sustainable payout ratio.
DP93.53%
EPS Next 2Y16.19%
EPS Next 3YN/A
MRTN Yearly Income VS Free CF VS DividendMRTN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
MRTN Dividend Payout.MRTN Dividend Payout, showing the Payout Ratio.MRTN Dividend Payout.PayoutRetained Earnings

MARTEN TRANSPORT LTD

NASDAQ:MRTN (10/10/2025, 8:45:13 PM)

After market: 10.48 0 (0%)

10.48

-0.31 (-2.87%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)07-16 2025-07-16/bmo
Earnings (Next)10-16 2025-10-16/amc
Inst Owners71.47%
Inst Owner Change0%
Ins Owners22.6%
Ins Owner Change0.48%
Market Cap854.33M
Analysts45.71
Price Target13.26 (26.53%)
Short Float %1.79%
Short Ratio1.58
Dividend
Industry RankSector Rank
Dividend Yield 2.27%
Yearly Dividend0.24
Dividend Growth(5Y)-14.12%
DP93.53%
Div Incr Years0
Div Non Decr Years2
Ex-Date09-16 2025-09-16 (0.06)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.96%
Min EPS beat(2)-1.96%
Max EPS beat(2)5.89%
EPS beat(4)2
Avg EPS beat(4)-1.07%
Min EPS beat(4)-22.6%
Max EPS beat(4)14.38%
EPS beat(8)2
Avg EPS beat(8)-6.17%
EPS beat(12)3
Avg EPS beat(12)-5.19%
EPS beat(16)6
Avg EPS beat(16)-0.32%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.61%
Max Revenue beat(2)-1.55%
Revenue beat(4)0
Avg Revenue beat(4)-2.97%
Min Revenue beat(4)-3.61%
Max Revenue beat(4)-1.55%
Revenue beat(8)0
Avg Revenue beat(8)-3.42%
Revenue beat(12)0
Avg Revenue beat(12)-3.51%
Revenue beat(16)3
Avg Revenue beat(16)-1.14%
PT rev (1m)-13.33%
PT rev (3m)-16.13%
EPS NQ rev (1m)-28.26%
EPS NQ rev (3m)-41.07%
EPS NY rev (1m)-3.23%
EPS NY rev (3m)-6.25%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)-2.19%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-1.01%
Valuation
Industry RankSector Rank
PE 40.31
Fwd PE 22.83
P/S 0.93
P/FCF N/A
P/OCF 6.97
P/B 1.11
P/tB 1.11
EV/EBITDA 6.27
EPS(TTM)0.26
EY2.48%
EPS(NY)0.46
Fwd EY4.38%
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)1.5
OCFY14.35%
SpS11.3
BVpS9.45
TBVpS9.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.11%
ROE 2.71%
ROCE 2.11%
ROIC 1.57%
ROICexc 1.64%
ROICexgc 1.64%
OM 2.01%
PM (TTM) 2.27%
GM 32.33%
FCFM N/A
ROA(3y)7.11%
ROA(5y)7.9%
ROE(3y)9.49%
ROE(5y)10.56%
ROIC(3y)6.79%
ROIC(5y)7.57%
ROICexc(3y)7.36%
ROICexc(5y)8.21%
ROICexgc(3y)7.36%
ROICexgc(5y)8.21%
ROCE(3y)9.12%
ROCE(5y)10.16%
ROICexcg growth 3Y-37.13%
ROICexcg growth 5Y-19.67%
ROICexc growth 3Y-37.13%
ROICexc growth 5Y-19.67%
OM growth 3Y-33.12%
OM growth 5Y-18.27%
PM growth 3Y-31.71%
PM growth 5Y-17.35%
GM growth 3Y-2.3%
GM growth 5Y-1.52%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 183.56%
Cap/Sales 23.17%
Interest Coverage 250
Cash Conversion 91.02%
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z 4.43
F-Score5
WACC9.15%
ROIC/WACC0.17
Cap/Depr(3y)180.36%
Cap/Depr(5y)176.4%
Cap/Sales(3y)19.81%
Cap/Sales(5y)19.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.85%
EPS 3Y-31.11%
EPS 5Y-14.56%
EPS Q2Q%-10%
EPS Next Y-10%
EPS Next 2Y16.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.76%
Revenue growth 3Y-0.34%
Revenue growth 5Y2.71%
Sales Q2Q%-6.63%
Revenue Next Year-4.76%
Revenue Next 2Y-0.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-60.34%
EBIT growth 3Y-33.35%
EBIT growth 5Y-16.06%
EBIT Next Year349.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-324.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44%
OCF growth 3Y-7.66%
OCF growth 5Y-2.94%